Absci Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Absci Corp 公司

Absci Corporation 是一家数据优先的生成人工智能 (AI) 药物创造公司。该公司将 AI 与可扩展的湿实验室技术相结合，为患者创造生物制剂。该公司的综合药物创造平台通过同时优化对开发和治疗效益都很重要多种药物特性，释放了加快临床时间和提高成功概率的潜力。通过训练数据、创造 AI 和验证湿实验室，其综合药物创造平台旨在设计生物制剂。该公司正在开发一个多元化的项目组合，重点是细胞因子生物学。它有三个专注于细胞因子生物学的全资内部管线项目，以及几个正在评估的其他未公开的管线项目。其全资管线项目包括 ABS-101、ABS-201 和 ABS-301。该公司的其他管线项目包括 ABS-501 和其他药物创造项目。

公司简介

公司代码ABSI

公司名称Absci Corp

上市日期Jul 22, 2021

CEOMr. Sean Mcclain

员工数量156

证券类型Ordinary Share

年结日Jul 22

公司地址18105 Se Mill Plain Blvd

城市VANCOUVER

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编98683

电话13609491041

网址https://www.absci.com/

公司代码ABSI

上市日期Jul 22, 2021

CEOMr. Sean Mcclain

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Sean Mcclain

Chief Executive Officer, Founder, Director

8.73M

+1.38%

Mr. Andreas Busch, Ph.D.

Chief Innovation Officer

131.48K

+61.36%

Dr. Zachariah (Zach) Jonasson, Ph.D.

Chief Financial Officer, Chief Business Officer

125.30K

-6.23%

Ms. Shelby J. Walker, J.D.

Chief Legal Officer

59.30K

--

Ms. Karen K. Mcginnis, CPA

Independent Director

29.50K

+96.67%

Mr. Daniel A. (Dan) Rabinovitsj

Independent Director

14.50K

--

Ms. Mary T. Szela

Director

--

Mr. Frans Van Houten

Independent Chairman of the Board

--

-100.00%

Prof. Dr. Menelas (Mene) Pangalos, Ph.D.

Independent Director

--

Dr. Joseph Sirosh, Ph.D.

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Sean Mcclain

Chief Executive Officer, Founder, Director

8.73M

+1.38%

Mr. Andreas Busch, Ph.D.

Chief Innovation Officer

131.48K

+61.36%

Dr. Zachariah (Zach) Jonasson, Ph.D.

Chief Financial Officer, Chief Business Officer

125.30K

-6.23%

Ms. Shelby J. Walker, J.D.

Chief Legal Officer

59.30K

--

Ms. Karen K. Mcginnis, CPA

Independent Director

29.50K

+96.67%

Mr. Daniel A. (Dan) Rabinovitsj

Independent Director

14.50K

--

收入明细

暂无数据

暂无数据

业务

地区

暂无数据

股东统计

更新时间: 8月16日周六

持股股东

股东类型

持股股东

占比

Fidelity Management & Research Company LLC

12.80%

ARK Investment Management LLC

6.72%

McClain (Sean)

5.84%

Redmile Group, LLC

5.52%

BlackRock Institutional Trust Company, N.A.

4.98%

其他

64.15%

持股股东

占比

Fidelity Management & Research Company LLC

12.80%

ARK Investment Management LLC

6.72%

McClain (Sean)

5.84%

Redmile Group, LLC

5.52%

BlackRock Institutional Trust Company, N.A.

4.98%

其他

64.15%

股东类型

持股股东

占比

Investment Advisor

35.03%

Investment Advisor/Hedge Fund

18.76%

Individual Investor

6.22%

Hedge Fund

3.58%

Corporation

3.17%

Research Firm

2.17%

Bank and Trust

0.28%

Venture Capital

0.13%

Insurance Company

0.03%

其他

30.62%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

309

100.84M

69.96%

-2.94M

2025Q1

316

100.15M

78.58%

-546.74K

2024Q4

298

92.04M

80.13%

-8.74M

2024Q3

280

90.06M

79.27%

-8.98M

2024Q2

257

91.26M

83.61%

+4.72M

2024Q1

236

84.09M

77.41%

+14.50M

2023Q4

202

58.01M

62.41%

-6.63M

2023Q3

196

57.87M

62.40%

-7.67M

2023Q2

191

58.28M

63.02%

-12.48M

2023Q1

181

65.82M

71.20%

-6.10M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Fidelity Management & Research Company LLC

18.39M

14.41%

+4.87M

+36.07%

Mar 31, 2025

ARK Investment Management LLC

10.96M

8.59%

+2.69M

+32.53%

Mar 31, 2025

McClain (Sean)

8.73M

6.84%

+119.00K

+1.38%

Mar 31, 2025

Redmile Group, LLC

8.25M

6.47%

--

Apr 25, 2025

BlackRock Institutional Trust Company, N.A.

6.25M

4.9%

+325.67K

+5.50%

Mar 31, 2025

The Vanguard Group, Inc.

4.69M

3.67%

-86.40K

-1.81%

Mar 31, 2025

Phoenix Ventures Partners II LP.

4.75M

3.72%

-4.61M

-49.28%

Mar 31, 2025

Fred Alger Management, LLC

4.29M

3.37%

-2.21M

-33.99%

Mar 31, 2025

Woodline Partners LP

1.39M

1.09%

+344.27K

+32.88%

Mar 31, 2025

Geode Capital Management, L.L.C.

2.00M

1.57%

+46.66K

+2.39%

Mar 31, 2025

持股ETF

更新时间: 8月6日周三

机构名称

占比

ARK Genomic Revolution ETF

2.39%

WisdomTree BioRevolution Fund

0.95%

iShares Micro-Cap ETF

0.06%

ProShares Ultra Nasdaq Biotechnology

0.04%

Invesco Nasdaq Biotechnology ETF

0.03%

iShares Biotechnology ETF

0.03%

Proshares Ultra Russell 2000

0.01%

ProShares UltraPro Russell2000

0.01%

iShares Russell 2000 Growth ETF

0.01%

Schwab U.S. Small-Cap ETF

0.01%

ARK Genomic Revolution ETF

占比2.39%

WisdomTree BioRevolution Fund

占比0.95%

iShares Micro-Cap ETF

占比0.06%

ProShares Ultra Nasdaq Biotechnology

占比0.04%

Invesco Nasdaq Biotechnology ETF

占比0.03%

iShares Biotechnology ETF

占比0.03%

Proshares Ultra Russell 2000

占比0.01%

ProShares UltraPro Russell2000

占比0.01%

iShares Russell 2000 Growth ETF

占比0.01%

Schwab U.S. Small-Cap ETF

占比0.01%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Absci Corp

2.690USD

Absci Corp

2.690

概览

公司

财务

分析